A B S T R A C T Nonhuman primates consuming diets containing cholesterol develop coronary artery atherosclerosis that we have found to be highly correlated with an increase in the size and cholesteryl ester content of plasma low density lipoproteins (LDL). The present studies were designed to determine whether the enlarged plasma LDL are produced directly by the liver of cholesterol-fed monkeys. African green monkeys were fed a diet containing 40% of calories as butter fat and either 0.16 mg cholesterol/kcal (control diet) or 0.78 mg cholesterol/kcal (test diet). The livers of these monkeys were perfused by recirculation with a lipoprotein-free medium for 4 h. The rate of accumulation of perfusate cholesterol was linear and greater in liver perfusates from test diet-fed vs. control diet-fed monkeys and was positively correlated with both the plasma cholesterol concentration and LDL size in the donor animal. All perfusate d < 1.063 g/ ml lipoprotein subfractions from livers of test diet-fed monkeys were enriched in cholesteryl ester severalfold over the corresponding subfractions from control dietfed monkeys and contained only the larger form of apolipoprotein B typical of plasma LDL. However, the perfusate lipoproteins in the LDL density range did not have an average size or composition typical of LDL from plasma. Rather, they were relatively enriched in phospholipid and unesterified cholesterol and were deficient in cholesteryl esters. In addition, perfusate high density lipoproteins were discoidal particles. These data show that the enzyme lecithin:cholesterol acyltransferase (LCAT) was essentially inactive in Received for publication 20 December 1982 and in revised form 9 March 1983. these perfusates and, as a result, the dietary cholesterol-induced enrichment of perfusate d < 1.063 g/ml lipoproteins with cholesteryl esters probably resulted from increased hepatic secretion of cholesteryl esters and not from modification of lipoproteins by LCAT during recirculating perfusion. In spite of this increase, enlarged cholesteryl ester-rich LDL were not found in the perfusate, suggesting that large molecular weight plasma LDL are not directly secreted by the liver but instead probably result from further intravascular metabolism of cholesteryl ester-enriched hepatic precursor lipoproteins.
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INTRODUCTION
The hypercholesterolemia that develops when nonhuman primates are fed a high-fat, high-cholesterol diet is consistently characterized by an increase in the molecular weight of plasma low density lipoprotein (LDL) (1, 2) . The increase in LDL molecular weight has been found to be highly correlated with the severity of coronary artery atherosclerosis (2) (3) (4) . Most of the increase in LDL size appears to be due to an increase in the cholesteryl ester content of the core of the particle, together with an increase in polar lipids and protein sufficient to maintain a 21-A-thick coat (1) .
The origin of the enlarged atherogenic LDL found in the plasma of monkeys fed a cholesterol-enriched diet is unknown. Numerous kinetic studies in rats (5) and humans (6) indicate that LDL can be derived from some nonhuman species (9, 10) , plasma LDL appear to be produced by one or more mechanisms separate from the catabolism of VLDL. Several studies indicate that the liver may be a direct source of plasma LDL. Nakaya et al. (11, 12) demonstrated de novo synthesis and secretion of lipoproteins with LDL density by the isolated perfused pig liver. Swift et al. (13, 14) isolated a cholesteryl ester-rich LDL from the hepatic Golgi apparatus of cholesterol-fed rats, and Noel et al. (15) demonstrated production of a cholesteryl ester-rich LDL by the isolated perfused liver of cholesterol-fed rats. Guo et al. (16) have recently identified cholesteryl ester-rich LDL in perfusates of livers from normal and cholesterol-fed guinea pigs, but suggest that many of these particles represent washout from liver of adsorbed plasma LDL.
The purpose of the present study was to characterize the lipoproteins produced by isolated perfused livers of monkeys fed diets containing either low or high amounts of cholesterol to determine whether the large molecular weight LDL found in the plasma of monkeys fed high-cholesterol-containing diets were produced directly by the liver. METHODS Animals and diets. Adult male African green monkeys (Cercopithecus aethiops) of the vervet subspecies weighing 3.8-5.8 kg were purchased from an animal importer (Primate Imports Corp., Port Washington, NY). Two groups were established, according to the level of cholesterol in the diet. The diets fed to the animals have been described previously (see 75-8B diets, reference 17) . The control diet contained 0. 16 an absolute rate of 10 ml/min, the weight of the liver was determined gravimetrically on a top-loading balance, and the flush rate was readjusted to 1 ml/min per g liver. This flow rate was maintained throughout the perfusion. The liver was suspended on a nylon screen in a closed plexiglass chamber. The temperature in the chamber was kept at 380C by an external heat lamp that was controlled by a temperature regulator (Yellow Springs Instrument Co., Yellow Springs, OH). The perfusate was oxygenated with 100% 02 by passage through a Silastic tubing (Dow Corning Corp., Midland, MI) lung, modified from the prototype of Hamilton et al. (18) to contain eight 6-ft lengths of tubing in parallel. All tubing in the system was preflushed with 4-6 liters of distilled water before use. The perfusion medium was maintained at 380C by a heat exchanger. Macroemboli were removed by a 25-mm filter holder (Millipore Corp., Bedford, MA) containing a support screen. A bubble trap was located in line just before the portal vein cannula. Lymph or seepage from the liver was continuously returned to a reservoir from which the recirculating perfusate was pumped.
To start an experiment, the liver was flushed with 1-1.5 liters of erythrocyte-free medium, after which perfusion by recirculation was begun with 300 ml of fresh, complete medium containing erythrocytes. To minimize contamination of hepatic lipoproteins by plasma lipoproteins trapped within the liver, recirculation perfusion was performed for 90 min, and the liver and entire apparatus were then flushed with 1-1.5 liters of fresh, erythrocyte-free medium. The flush medium was subsequently replaced with 300 ml of fresh medium containing erythrocytes, and recirculation perfusion was carried out for an additional 4 h.
The perfusion medium consisted of Krebs-Henseleit original Ringer bicarbonate (10) 40 h at 60,000 rpm, 4°C, in a 60 Ti rotor (Beckman Instruments, Inc.) using a model L2-65B ultracentrifuge (Beckman Instruments, Inc.). The tubes were sliced and the top fraction containing the lipoproteins was removed. The lipoproteins were then washed and concentrated by recentrifugation at the same density. In the second method, used in the majority of cases, VLDL (d < 1.006 g/ml lipoproteins) were initially isolated by ultracentrifugation of the perfusate for 18 h at 60,000 rpm in the 60 Ti rotor. The density of the infranate was then raised to 1.225 g/ml as before, and 1.006 < d < 1.225 g/ml lipoproteins were floated by ultracentrifugation as described above.
After isolation by ultracentrifugation, lipoproteins were separated by size using gel filtration chromatography on a 1.5 cm X 90-cm column of Bio-Gel A-15m, 200-400 mesh (Bio-Rad Laboratories, Richmond, CA) into region I, II, III, and IV lipoproteins (Fig. 6) (19) . The material within these size populations was then pooled and concentrated by dialysis against 40% Dextran T-500 (Pharmacia Fine Chemicals, Piscataway, NJ), containing 0.01% EDTA, 0.02% NaN3, pH 7.2-7.5. For region I, II, and III lipoproteins, samples containing 1-5 mg of cholesterol were adjusted by dialysis to a density of 1.06 g/ml in a final volume of 4.0 ml. They were then placed in an ultracentrifuge tube for the SW 40 rotor, were overlayered with 3.0 ml each of KBr solutions with densities of 1.04 g/ml, 1.019 g/ml, and 1.006 g/ml, and were centrifuged for 24 h at 40,000 rpm, 15°C, in a Beckman L5-50 ultracentrifuge. For region IV lipoproteins, the sample was adjusted by dialysis to a density of 1.21 g/ ml in a final volume of 4.0 ml and was overlayered in the ultracentrifuge tube with 3.0 ml each of KBr solutions with densities of 1.11 g/ml, 1.08 g/ml, and 1.05 g/ml. The sample was centrifuged for 40 Lipoprotein radiolabeling. For studies of LDL catabolism by the perfused liver, LDL were isolated by agarosecolumn chromatography (19) from the plasma of test dietfed animals that subsequently served as donors for liver perfusion. LDL were radiolabeled with 1251 as previously described (20) , by the method of McFarlane (21) as modified by Bilheimer et al. (22) . Levels of radioactivity in samples were determined with a 1185 series automatic gamma counting system (Searle Analytic Inc., Des Plaines, IL). Specific activity of radiolabled LDL was 500-1,000 cpm/gg of protein, and 3-5% of the radioactivity was extractable with chloroform/methanol, 2:1 (vol/vol).
Analytical methods. Plasma cholesterol concentration was measured according to the AutoAnalyzer II (Technicon Instruments Corp., Tarrytown, NY) methodology of Rush et al. (23) . Plasma apolipoprotein B (apo B) concentration was measured by electroimmunoassay, essentially as described by Rosseneu et al. (24) . Lipids were extracted from isolated lipoprotein subfractions with chloroform/methanol, 2:1, and lipoprotein cholesterol was measured according to the method of Rudel and Morris (25) . Lipid phosphorus was measured according to the method of Fiske and Subbarow (26) . Protein was estimated according to Lowry et al. (27) , with the modification of Kashyap et al. (28) with bovine serum albumin as the standard. Thin-layer chromatography of lipid extracts was performed on silica gel 60F-254 plates (Brinkmann Instruments, Inc., Westbury, NY), using a solvent system of Skellysolve B/diethyl ether/glacial acetic acid (146:50:4). Separated lipid classes were eluted from the gel according to Skipski and Barclay (29) . Triglyceride was measured according to Sardesai and Manning (30) . The apoproteins of isolated lipoprotein subfractions were identified by polyacrylamide gel electrophoresis (PAGE) in sodium dodecyl sulfate (SDS). Lipoprotein samples were dialyzed against distilled water containing 0.01% EDTA, pH 7.4, and lyophilized. They were then resolubilized in 1% SDS and apoproteins were separated in a horizontal slab gel as described previously (31 
RESULTS
Plasma lipoprotein responses to diet. Plasma samples were taken from each animal twice during the 24-60 mo the animals consumed the diets, and the lipoproteins were separated and analyzed. The results are summarized in Table I . The animals consuming the test diet had higher average concentrations of total plasma cholesterol, LDL, and apo B and had higher LDL molecular weights.
Viability of perfused livers. Liver weights averaged -100 g and were the same in both control and test dietLipoproteins of Perfused Livers 223 Fig. 6 A) . A considerable amount of material from perfusate lipoproteins 1.006 < d < 1.225 g/ml eluted in regions I, II, and III and in region IV. Region I consisted of irregularly shaped particles that appeared to be membranous or vesicular in structure (Fig. 6 B) FIGURE 5 Agarose-column chromatography elution profiles of liver perfusate and plasma lipoproteins from two representative test diet-fed animals. (A) The liver was perfused for a 90-min period, followed by a 4-h period (Methods). All lipoproteins were isolated together by ultracentrifugal flotation at d 1.225 g/ml from the perfusate after-the 4-h period of perfusion and from the plasma of the liver donor. Lipoproteins were then separated on a 1.5 X 90 cmcolumn of 4% agarose (Bio Gel A-15m, Bio-Rad Laboratories), as previously described (17 (Fig. 6 E) . Another type appeared as round, free-standing particles that were 108±3 A in diameter. (Fig. 7) . About 85% of the cholesterol in the perfusate region I lipoproteins was recovered between the densities of 1.02 and 1.065 g/ml (Fig. 7 A) . About 65% of the cholesterol in lipoproteins from regions II and III was present in the 1.02 < d < 1.065 g/ml interval and 30% was in the 1.006 < d < 1.02 g/ml interval (Fig. 7 B) . In IV lipoproteins (Fig. 7 C) , 35, 40 , and 20% of the cholesterol was contained in the density regions of d < 1.07 g/ml, 1.07 < d < 1.11 g/ml, and 1.11 < d < 1.21 g/ml, respectively. No consistent diet-related differences were detected in the percentage distribution of cholesterol among the density subfractions.
Composition of perfusate lipoproteins. (Fig. 6 E) . These were the only lipoproteins isolated from liver perfusates of test dietfed animals that were not enriched in cholesteryl ester, compared with the same subfractions from control diet-fed animals, although perfusates of test diet-fed animals accumulated moderately higher amounts of these subfractions compared with perfusates of control diet-fed animals.
SDS-PAGE. The apoproteins of the major perfusate lipoprotein subfractions were identified using SDS-PAGE (Fig. 8) . The apoproteins of perfusate VLDL from animals on either the control or test diet were primarily apo B and apo C along with small amounts of apo A-I and apo E (Fig. 8 A) . Perfusate subfractions from region I, II, and III from both control and test diet-fed animals contained primarily apo B (Fig. 8 B) . Some apo E was detected in the region II + III subfractions. In the HDL subfractions, IVI.07-1.11 and IVI.11-1l21 apo A-I was the predominant apoprotein; bands in the region of apo A-II and apo C were also present (Fig.  8 B) . Apo E was another major component of subfraction IVI 07-1.11 The HDL subfractions from test dietfed animals, especially IVI.07-1.11, were consistently enriched in apo E, compared with the same subfractions from control diet-fed animals. Apo B was not detected in perfusate HDL from either control or test diet-fed animals. 181 (15) 254±74 (12) 277 (16) 1190±73 (25) 1830±417 (23) 744 (69) 600±15 (48) 511 (31) 583±131 (29) 1,000 The different molecular weight forms of apo B were apo B, labeled B2, is shown by including a sample of separated in 5% polyacrylamide gels (Fig. 8 C) . In all thoracic lymph duct chylomicra in well 7 of Fig. 8 part of a population of much larger lipoproteins that were relatively poor in cholesteryl ester, whereas plasma LDL are typically 45-50% by mass cholesteryl ester (1) . The failure to isolate a distinct population of plasma LDL-like particles in the perfusate could not be attributed to rapid uptake of newly secreted LDL particles, because minimal amounts of LDL were catabolized during perfusion (Fig. 9) . Free fatty acids, known to stimulate the synthesis and secretion of triglyceride by the liver, were not included in the perfusion medium in our studies. Consequently, the availability of free fatty acids to the liver was probably lower than normal. However, this would be expected to result in the secretion of relatively triglyceride-poor particles, more like plasma LDL in composition, rather than to make their presence in the perfusate less likely. These results have led us to reject our hypothesis that large LDL are secreted directly by the liver in nonhuman primates; rather, it appears that the lipoproteins secreted by the liver are more likely immature precursors to mature plasma LDL.
The question then becomes which of the various lipoproteins secreted by the liver are precursors to plasma LDL. This question was not addressed directly by these studies but our data combined with those in the literature allow us to speculate. Several studies in rats (5) and man (6) have shown that plasma VLDL are precursors to plasma LDL. However, it remains to be established what portion of the plasma LDL are derived from plasma VLDL. Indeed, one study in rats (9) indicates that only a small portion of the apo B of plasma LDL appears to be derived from apo B of plasma VLDL, and studies in cynomolgus monkeys suggest that a similar situation exists in this primate (32) . It is possible that newly secreted hepatic lipoproteins such as we have isolated are rapidly converted to LDL and do not normally accumulate in the plasma to a significant degree. Such a hypothesis implies that there is a rapidly turning over plasma pool of LDLprecursor, presumably triglyceride-rich lipoproteins, that is metabolically distinguishable from the plasma VLDL. In this regard, Illingworth (10) has provided evidence that the low levels of plasma VLDL in squirrel monkeys is in part due to the high catabolic rate and rapid turnover of VLDL. Furthermore, Illingworth's studies in squirrel monkeys suggested that LDL are derived from particles other than VLDL. We suspect that this is also true for other species of nonhuman primates, including the African green monkey of these studies.
A significant hepatic secretion of the d 1.006-1.063 g/ml precursor lipoproteins as we have observed here may provide an explanation for Illingworth's findings. That a variety of hepatic lipoproteins may give rise to plasma LDL is an attractive hypothesis, for it may explain the polydispersity of plasma LDL described in both human beings (33) (34) (35) and in several species on nonhuman primates (1, 20, 36 (Fig. 4 B) . (40) . All these data suggest that LCAT is absent or inactive in the perfusates from both control and test diet-fed animals. Therefore, the differences observed in the rate of accumulation of cholesterol in the perfusates are primarily due to differences in the hepatic secretion rate of cholesteryl esters (Table III) . The increase in size of plasma LDL in cholesterolfed monkeys has been shown to be primarily due to an increased number of cholesteryl oleate and cholesteryl palmitate molecules per LDL particle (2, 41) . Thus, the cholesteryl esters that increase in number in large molecular weight LDL are more likely to have been formed by acyl-CoA cholesteryl O-acyltransferase than by LCAT (42, 43 The only form of apo B that was detected on the perfusate lipoproteins including the VLDL was the large molecular weight form, apo Bloo, termed apo B-1 in Fig. 8 . Sparks and Marsh (44) have provided evidence that in rats, the large molecular weight form of apo B on serum triglyceride-rich lipoproteins preferentially becomes associated with plasma LDL, whereas the lower molecular weight form is rapidly catabolized by the liver. We have found that plasma LDL in monkeys contain primarily apo B-1, whereas intestinally derived chylomicra contain predominantly the smaller apo B-2 or apo B48 (45) .
Since the perfusion medium was continuously re-circulated through the liver in these studies, the (4) , it seems appropriate to comment upon the potential extrapolation of these results in the primate model to the situation in human beings. In selected patients with premature coronary heart disease, Sniderman (48) has pointed out an apparent relationship between the elevated LDL apo B to cholesterol ratio and the occurrence of coronary artery atherosclerosis. Krauss and Burke (35) have demonstrated a remarkable degree of variability in the heterogeneity of LDL among individuals. Kesaniemi and Grundy (49) have carried out kinetic studies of LDL turnover in patients that suggest a significant degree of variability in LDL apo B production rates. These studies in human beings emphasize the heterogeneity among individuals in the types and amounts of LDL present and their relationships to coronary heart disease. The heterogeneity in LDL described among African green monkeys (1, 4) appears to be part of a similar process. The findings presented here in perfused monkey livers suggest that much of the LDL heterogeneity may be related to the secretory products of the liver, most of 3Johnson, F. L., R. W. St. Clair, and L. L. Rudel. Unpublished observations. 234 which appear to require significant intravascular remodeling before obtaining the composition typical of plasma LDL. These data would appear to establish a potentially important role for the liver in determining the extent of plasma LDL heterogeneity.
